针对心力衰竭中的炎症:随机临床试验的不断发展的见解和未来方向
Reina Nagasaka1, Ellis Kim1, Andrew P Ambrosy2,3
1The Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Heart failure reviews
|June 17, 2025
概括
炎症在心力衰竭 (HF) 中起着关键作用,但抗炎治疗产生了不一致的结果. 未来的HF试验应考虑疾病阶段和患者症状,以更好地针对治疗.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 翻译研究是翻译研究.
背景情况:
- 心力衰竭 (HF) 是死亡的主要原因,炎症既是原因又是后果.
- 观察和实验研究证实了炎症在HF病变发生中的中心作用.
- 针对HF炎症的临床试验显示出不同的结果.
研究的目的:
- 审查针对HF炎症的临床试验.
- 分析HF阶段和临床表型对试验结果的影响.
- 为未来炎症调节性HF疗法的设计提供信息.
主要方法:
- 临床试验的系统审查.
- 分析的重点是疾病的阶段和症状.
- 对治疗目标和机制的评估.
主要成果:
- 在HF试验中,抗炎疗法的结果不一致.
- 归因于HF阶段,临床表型和治疗方法的差异的可变性.
- 在未来的研究中需要精确的患者分层.
结论:
- 对抗炎症治疗的有效性来说,HF的分期和干预的时间是至关重要的.
- 未来的试验需要对向治疗的高频基质有更深入的了解.
- 优化炎症调节策略需要考虑疾病异质性.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
Heart Failure III: Clinical Manifestations
60
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
60


